Clin2
NCT07608770Possibly a fitRecruiting

CBL-514 injection to reduce belly fat

Subcutaneous Fat

Treatments studied

This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
250 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Age 18 or older
  • BMI between 18.5 and 30 (roughly normal to slightly overweight) and weigh at least 50 kg (110 lbs)
  • Have moderate to significant belly fat (Grade 3 or 4 on assessment scales)
  • Not pregnant, nursing, or unwilling to use contraception for 90 days after last injection
  • No recent belly surgery, liposuction, or other fat-reduction procedures in the past year
  • Not taking weight-loss medications, GLP-1 drugs (like Ozempic or Mounjaro), or steroids in the past 6 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07608757Not yet recruiting· Phase 2
Injection to reduce belly fat

This study tests an injection called CBL-514 that may help reduce belly fat. It is for adults with extra abdominal fat who want a non-surgical option.

South Yarra, Victoria
NCT07526974Not yet recruiting· Phase 3
Injectable treatment to reduce belly fat

This study tests a new injectable treatment, CBL-514, to reduce belly fat. It may help people who have stubborn abdominal fat that doesn't go away with diet and exercise.

Encinitas, California
NCT07140939Recruiting· Phase 3
Reducing belly fat with an injection: CBL-514 trial

This trial tests a new injection called CBL-514 that is designed to reduce fat under the skin in the belly area. It might help people who are dissatisfied with stubborn abdominal fat that doesn't go away with diet and exercise.

Encinitas, California
NCT07733947Not yet recruiting· Phase 3
Long-term safety and lasting effects of fat-reducing injection

This study checks whether the fat-reducing effects from the earlier treatment last over time, and whether the treatment is safe to use long-term. It is only for people who already took part in the first part of this study.

Encinitas, California
NCT07749742Recruiting· Phase 1
Study of MI226 injection for belly fat

This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.

Beijing, Beijing Municipality
NCT07802431Recruiting
Body contouring treatment for belly and love handles

This trial tests a new non-invasive device to reduce fat in the belly and sides (love handles). It may help people who have stubborn fat in these areas despite a stable weight.

Nuevo León, Monterrey

Hear when a new Subcutaneous Fat trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.